Deane Retirement Strategies, Inc. Abb Vie Inc. Transaction History

Deane Retirement Strategies, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 07, 2020	SELL	$85.91 - $100.83 $1.92 Million - $2.26 Million	-22,383 Closed	0 $0
Q2 2020 Jul 07, 2020	SELL	$73.37 - $98.18 $18,709 - $25,035	-255 Reduced 1.13%	22,383 $2.2 Million
Q1 2020 Apr 03, 2020	BUY	$64.5 - $97.79 $13,738 - $20,829	213 Added 0.95%	22,638 $1.73 Million
Q4 2019 Jan 15, 2020	SELL	$72.13 - $90.25 $681,772 - $853,043	-9,452 Reduced 29.65%	22,425 $1.99 Million
Q3 2019 Oct 18, 2019	BUY	$62.98 - $75.72 $2.01 Million - $2.41 Million	31,877 New	31,877 $2.41 Million
Q2 2018 Aug 01, 2018	SELL	$89.78 - $106.23 $0 - $0	0 Closed	0 $0
Q1 2018 Apr 11, 2018	SELL	$92.01 - $123.21 $2.08 Million - $2.78 Million	-22,553 Closed	0 $0
Q4 2017 Jan 10, 2018	SELL	$89.56 - $98.21 $44,690 - $49,006	-499 Reduced 2.16%	22,553 $2.18 Million
Q3 2017 Oct 19, 2017	BUY	$69.85 - $89.22 $1.61 Million - $2.06 Million	23,052	23,052 $2.05 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Deane Retirement Strategies, Inc., based on Form 13F filings with the SEC.

Stay updated on Deane Retirement Strategies, Inc. with notifications on news.